Jun
2026
Shanghai New International Expo Center
Visit us
stand W2B01, Pharma Ingredients

BrightGene Bio-Medical Technology Co., Ltd.

About Us

Brightgene Bio-medical Technology Co., Ltd. (Stock code: 688166) is a research and development-driven high-tech pharmaceutical company dedicated to the development and production of original new drugs and high-end generic drugs. With professional R&D capabilities and commercialization capabilities, it provides patients with products of excellent value.With the goal of "continuous innovation and health protection", Brightgene seeks solutions for unmet clinical needs. After years of continuous R&D and exploration, Brightgene has made breakthroughs in the field of targeted tumor therapy and immunotherapy, as well as the treatment of fatty liver and diabetes, and many original ...

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W2B01, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • MMAF

    Product MMAF

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • MMAE

    Product MMAE

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • Maytansinol

    Product Maytansinol

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-4

    Product DM-4

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-1

    Product DM-1

    • Status: Validated • Usage:  Antibody-drug Conjugate